Activation of STAT3 in Human Gastric Cancer Cells via Interleukin (IL)-6-Type Cytokine Signaling Correlates with Clinical Implications

Interleukin-6 Mediates Epithelial–Stromal Interactions and Promotes Gastric Tumorigenesis

(2013) Hiroto Kinoshita et al.   PLoS One

Activation of the Notch1/STAT3/Twist signaling axis promotes gastric cancer progression

(2012) Kai-Wen Hsu et al.   CARCINOGENESIS

Targeting STAT3 in gastric cancer

(2012) Andrew S Giraud et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Constitutive activation of STAT3 is predictive of poor prognosis in human gastric cancer

(2012) Hua Xiong et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Inhibition of activated Stat3 reverses drug resistance to chemotherapeutic agents in gastric cancer cells

(2011) Shuling Huang et al.   CANCER LETTERS

Inhibition of STAT3 Signaling Pathway by Nitidine Chloride Suppressed the Angiogenesis and Growth of Human Gastric Cancer

(2011) J. Chen et al.   MOLECULAR CANCER THERAPEUTICS

Suppression of STAT3 and HIF-1 Alpha Mediates Anti-Angiogenic Activity of Betulinic Acid in Hypoxic PC-3 Prostate Cancer Cells

(2011) Jimin Shin et al.   PLoS One

T-regulatory lymphocytes in peripheral blood of gastric and colorectal cancer patients

(2011) Antoni M Szczepanik   WORLD JOURNAL OF GASTROENTEROLOGY

Natural Killer Cell Cytotoxicity and Immunosuppressive Cytokines (IL-10, TGF-β1) in Patients with Gastric Cancer

(2010) Andrzej Szkaradkiewicz et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

STAT3 as a prognostic marker in human gastric cancer

(2009) Cameron B Jackson et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

STAT3 expression in gastric cancer indicates a poor prognosis

(2008) Dae-Young Kim et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY